Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Avergas, Amy
NCT06246110: A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer	Recruiting	2	70	US	EIK1001, Pembrolizumab, Paclitaxel, Pemetrexed, Carboplatin	Eikon Therapeutics	NSCLC	12/26	12/27
NCT04499053: Durvalumab and Tremelimumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer	Recruiting	2	18	US	Durvalumab, Tremelimumab	Georgetown University, AstraZeneca	Carcinoma, Non-Small Cell Lung	12/24	12/24